Johnson & Johnson's single-dose vaccine next to seek emergency use authorization
1 min read
fairly difficult
Experts say Johnson & Johnson's vaccine could be a game-changer since it only requires one shot and does not require ultra-cold storage, like the Pfizer shots.
HOUSTON — Johnson & Johnson says it plans to seek emergency use authorization in February, which would make it the third vaccine to be considered by the FDA.

The shot was developed by Janssen Pharmaceuticals, a Belgium based division of Johnson & Johnson. It would be the first COVID-19 vaccine that only requires one dose.

Johnson & Johnson's…
Stephanie Whitfield
Read full article